期刊文献+

血清超敏C反应蛋白 白细胞介素测定与糖尿病大血管病变的相关性 被引量:4

Relationship between serum levels of high-sensitivity C reactive protein,interleukin-6,interleukin-18 and macroangiopathy complicated by type 2 diabetes mellitus
下载PDF
导出
摘要 目的探讨超敏C反应蛋白(hs-CRP)、白细胞介素6(IL-6)和白细胞介素18(IL-18)与2型糖尿病并发大血管病变的相关性。方法采用酶联免疫吸附试验法测定50例2型糖尿病(DM)患者和30名健康对照组血清hs-CRP、IL-6和IL-18的水平,并进行相关性分析。结果2型DM组hs-CRP、IL-6和IL-18水平显著高于健康对照组,差异有统计学意义(P<0.01),并发大血管病变患者hs-CRP、IL-6和IL-18较非大血管病变者差异有统计学意义(P<0.05),相关分析显示:血清IL-6、IL-18与hs-CRP呈显著正相关(r=0.261,P<0.05;r=0.320,P<0.05),hs-CRP与空腹血糖(r=0.296,P<0.05)呈正相关。结论hs-CRP、IL-6和IL-18在2型DM并发大血管病患者中升高,可能在2型DM的发病及进展过程中起重要的作用。 Objective To investigate the relationship between serum levels of high-sensitivity C reactive protein (hs-CRP) ,interleukin-6 (IL-6) ,interleukinq8 (ILq8) and maeroangiopathy complicated by type 2 diabetes mel- litus. Methods ELISA assay was applied to measuring serum levels of hs-CRP,IL-6 and IL-18 in 50 patients with type 2 diabetes mellitus (DDM group,in which 20 cases were complicated with macroangiopathy) and 30 healthy controls (control group). Then the correlation analysis was performed. Results The serum levels of hs-CRP,IL-6 and IL-18 were signifinicantly elevated in DDM group than those in control group (P〈0.01). There was a significant difference of hs-CRP,IL-6 and IL-18 levels between type 2 DM patients with and without macrovascular complications (P〈0.01). LTnivariate linear regression analysis showed significant positive correlation existed between serum IL-6,IL-18 and hs-CRP (r= 0. 261, P〈0.05; r= 0. 320, P(0.05, respectively) ; hs-CRP and fasting blood glucose (FBG) (r=0. 296,P%0.05).Conclusion Elevated levels of hs-CRP,IL-6 and IL-18 may play an important role in occurrence and development of type 2 diabetes mellitus.
出处 《检验医学与临床》 CAS 2008年第23期1413-1414,共2页 Laboratory Medicine and Clinic
关键词 超敏C反应蛋白 白细胞介素-6 白细胞介素-18 糖尿病 大血管病变 high-sensitivity C reactive protein interleukin-6 interleukin-18 diabetes mellitus macroangiopathy
  • 相关文献

参考文献8

二级参考文献19

  • 1李猛,郭晓玲,贺晓兵.血清白细胞介素-18与冠心病的相关性研究[J].内蒙古医学杂志,2005,37(9):778-781. 被引量:1
  • 2张燕,黎莉,张运,谭红伟,马志勇,王颖,李静,朱圆圆.冠心病心绞痛患者白细胞介素18水平的变化[J].中国动脉硬化杂志,2005,13(4):500-502. 被引量:5
  • 3Yudkin JS , Stehouwer CD , Emeis JJ , et al. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfuction: a potential role for cytokines originating from adipose tissue. Arerioscler Thromb Vase Biol ,
  • 4Marz W, Wieland H. HMG-CoA reductase inhibition: anti inflammatory effects beyond lipid lowering. Herz , 2000 , 25 : 117-125.
  • 5Hojo Y , Ikeda U, Katsuki T , et al. Interleukin 6 expression in coronary circulation after coronary angioplasty as a risk factor for restenosis. Heart, 2000,84: 83 -87.
  • 6Davies MJ. The pathophysiology of acute coronary syndromes.Heart , 2000 , 83 : 361-366.
  • 7Anderson JL , Caripuist JF , Muhlestein JB , et al. Evalution of Creactive protein. an inflammatory marker and infection serology as risk factor for coronary artery disease and myocardial infarction. J Am Coil Caridol , 1998 , 32: 35-38.
  • 8叶任高.内科学第5版[M].北京:人民卫生出版社,2002.471—479.
  • 9Blankenberg S, Luc G, Ducimetiere P, et al. Interleukin-18 and the risk of coronary heart disease in European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation, 2003, 108(20) : 2453-2459.
  • 10Tsutsui H, Matsui K, Okamura H, et al. Pathophysiological roles of interleukin-18 in inflammatory liver diseases, Immunol Rev,2000, 174: 192-209.

共引文献70

同被引文献31

  • 1陈晓旭,郭哲.C-反应蛋白检测技术及临床应用[J].实用预防医学,2006,13(4):1098-1100. 被引量:10
  • 2何穗,龙国文.白细胞介素-18与冠心病研究进展[J].国际检验医学杂志,2006,27(9):823-824. 被引量:3
  • 3Volanakis JE.Human C-reactive protein:expression,structure,and function.Mol Immunol,2001,38(2/3):189-197.
  • 4钱立荣.糖尿病临床指南[M].北京:北京医科大学出版社,2002:214.
  • 5Du Clos TW.Function of C-reactive protein[J].Ann Med,2000,32(4):274-278.
  • 6Barzilay JI,Abraham L,Heckbert SR,et al.The relation of markers of inflammation to the development of glucose disorders in the elderly:the Cardiovascular Health Study[J].Diabetes,2001,50(10):2384-2389.
  • 7Mahmoud RA,el-Ezz SA,Hegazy AS.Increased serum levels of interleukin-18 in patients with diabetic nephropathy[J].Ital J Biochem,2004,53(2):73-81.
  • 8Oikawa Y,Shimada A,Kasuga A,et al.Systemic administration of IL-18 promotes diabetes development in young nonobese diabetic mice[J].J Immunol,2003,171(11):5865-5875.
  • 9Festa A,D'Agostino R Jr,Howard G,et al.Chronic subclinical inflammation as part of the insulin resistance syndrome:the Insulin Resistance Atherosclerosis Study (IRAS)[J].Circulation,2000,102(1):42-47.
  • 10Navarro JF,Mora C,Muros M,et al.Urinary tumour necrosis factor-alpha excretion independently correlates with clinical markers of glomerular and tubulointerstitial injury in type 2 diabetic patients[J].Nephrol Dial Transplant,2006,21(12):3428-3434.

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部